Treatment Set TS329413 - Treatment Set TS329413

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.

Field	Value
NDC Code:	49288-0771
Proprietary Name:	Treatment Set TS329413
Suffix:
Non-Proprietary Name:	Treatment Set TS329413
Dosage Form:	INJECTION, SOLUTION
Method:	INTRADERMAL; SUBCUTANEOUS
Original Marketing Date:	31-10-1986
Category Name:	BLA
Application Number:	BLA102223
Labeler:	ANTIGEN LABORATORIES, INC.
Substance Name:	CANDIDA ALBICANS; COCHLIOBOLUS SATIVUS; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FRAXINUS AMERICANA POLLEN; IVA ANNUA VAR. ANNUA POLLEN; PERIPLANETA AMERICANA; SALSOLA KALI POLLEN
Active Numerator Strength:	.01; .01; 1000; 1000; .01; .01; .01; .01
Active Ingredient Unit:	g/mL; g/mL; [AU]/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL
Pharm Classes:	Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE]
DEA Schedule: